Market Overview - All three major U.S. stock market indices closed slightly higher on February 17, 2026, despite declines in software equities, influenced by a softer-than-expected Consumer Price Index and a stronger-than-anticipated jobs report [1][2] Investment Strategy - The current market uncertainty may lead investors to prefer low-leverage stocks for financial resilience and capital preservation, with recommendations including Orion Group (ORN), Copa Holdings (CPA), Coeur Mining (CDE), Tim S.A. (TIMB), and Evercore (EVR) [3][11] Low-Leverage Stocks - Low-leverage stocks are preferred as they are generally less risky, especially during volatile market conditions. The debt-to-equity ratio is a key metric for assessing a company's financial risk, with lower ratios indicating better solvency [7][8] Company Highlights - **Orion Group (ORN)**: Acquired J. E. McAmis, Inc. and JEM Marine Leasing LLC for approximately $60 million, with 2026 earnings expected to improve by 63.6% [15][17] - **Copa Holdings (CPA)**: Reported a 9.6% increase in fourth-quarter operating revenues and a 5.3% rise in EPS, with 2026 revenues projected to grow by 11.5% [18][19] - **Coeur Mining (CDE)**: Increased mineral reserves to 4.4 million ounces of gold and 274.4 million ounces of silver, with 2026 earnings expected to jump by 143.3% [20][22] - **Tim S.A. (TIMB)**: Announced acquisition of 51% of I-Systems for approximately $180 million, aiming to expand in the broadband segment, with 2026 revenues expected to rise by 10.3% [23][24] - **Evercore (EVR)**: Reported a 32% increase in fourth-quarter revenues and a 50% rise in adjusted EPS, with 2026 revenues projected to grow by 22.6% [24][25]

Core Insights - Silver experienced a remarkable rally, surging 137% from February 2025 to February 2026, with the iShares Silver Trust (SLV) climbing from $29.46 to $69.72 [1] - The volatility in January 2026, triggered by speculation regarding the Federal Reserve chair, led to a 17.5% selloff, testing investor conviction [1] - The current market sentiment around silver remains bullish, with retail investors showing signs of recovery after the January shakeout [1] Silver Price Action - Silver's 137% gain over the past year significantly outpaces its 176% return over the previous five years, compressing a typical five-year performance into just twelve months [1] - The metal briefly touched $95 before reversing during the January volatility, indicating extreme price fluctuations [1] - Year-to-date, SLV is up 8.2%, reflecting ongoing volatility beneath the surface [1] ETF Flows and Investor Sentiment - The iShares Silver Trust holds $51.5 billion in net assets with a 0.5% expense ratio, indicating strong investor interest [1] - Sentiment on Reddit fluctuated during the January crash, with posts highlighting both significant losses and gains from SLV put options [1] - By mid-February, sentiment had rebounded to a bullish range of 64-68, suggesting a repositioning among retail investors [1] Silver Miners Performance - Silver mining stocks have amplified gains, with First Majestic Silver (AG) returning 304%, Hecla Mining (HL) at 256%, and Coeur Mining (CDE) at 211% [1] - The valuations of these mining companies have expanded significantly, with First Majestic trading at 164x trailing earnings and Pan American Silver (PAAS) at 33x [1] Drivers of Silver Demand - Industrial demand for silver remains robust, driven by sectors such as solar panel production, AI infrastructure, and electronics manufacturing [1] - Central bank gold buying indirectly supports silver prices through the gold-to-silver ratio, highlighting the interconnectedness of precious metals [1] - Key factors to watch include the sustainability of industrial demand, miners' production management, and the behavior of retail investors post-January [1]

Core Insights - Coeur Mining, Inc. (CDE) is expected to report fourth-quarter 2025 results on February 18, with anticipated earnings of 42 cents per share, reflecting a 282% year-over-year increase [1][2][8] - The company's performance is driven by operational momentum from the Las Chispas and Rochester mines, disciplined cost control, and higher realized gold and silver prices [1][8] Earnings Expectations - The Zacks Consensus Estimate for fourth-quarter earnings has increased over the past 30 days, with the current estimate at 42 cents per share [2] - CDE has beaten the Zacks Consensus Estimate for earnings in two of the last four quarters, with an average earnings surprise of approximately 107% [4] Operational Performance - CDE's production is expected to benefit from record output across key assets, including Las Chispas, Palmarejo, Rochester, Kensington, and Wharf, contributing to robust volumes of gold and silver [10] - The company has implemented several operational improvements, such as smoother mine sequencing and better mill throughput, which are likely to enhance margins and cash flow [11][12] Financial Metrics - CDE's adjusted costs applicable to sales were reported at $1,215 per ounce for gold and $14.95 per ounce for silver, supporting healthy spreads relative to realized prices [12] - The company is currently trading at a forward 12-month sales multiple of 5.00, which is approximately a 6% discount compared to the industry average of 5.03X [17] Stock Performance - CDE's shares have increased by 216.8% over the past year, significantly outperforming the Zacks Mining – Non Ferrous industry's increase of 76.6% and the S&P 500's rise of 14% [14] - The stock's performance is also favorable compared to peers such as Lundin Mining Corporation, Southern Copper Corporation, and Freeport-McMoRan, which have seen increases of 196.5%, 103.4%, and 57.2%, respectively [14] Investment Thesis - Coeur Mining is positioned for stronger earnings momentum in Q4 2025 due to consistent production, higher precious metal prices, and improved operational efficiency [20][22] - The successful ramp-up of key projects and improved scale efficiencies are expected to lower unit costs and expand margins, enhancing financial flexibility [22]

Core Insights - Coeur Mining (CDE) is positioned for rapid growth in 2026 due to the successful completion of an acquisition [1] Company Overview - Coeur Mining is highlighted as an interesting player in the gold mining sector [1] - The company is expected to leverage its acquisition to enhance its market position and growth potential [1]

The last time I have covered Coeur Mining ( CDE ) was in October 2025 . Then my main concern was financial health risk, also sensitivity to metal prices. At the time, I was just cautiously optimistic. Wondering whetherI’m an independent equity trader and licensed financial advisor focused on uncovering high-upside opportunities in overlooked sectors especially focusing on small-caps, energy, commodities, and special situations. My investment strategy is based on growth. I look for fundamental momentum (EPS, ...

Core Insights - Coeur Mining, Inc. (CDE) is trading at a forward 12-month price-to-sales multiple of 5.5X, which is above the industry average of 5.13X [1] - CDE has experienced a significant stock price increase of 229.9% over the past year, outperforming the Zacks Mining-Non Ferrous industry's increase of 94.3% and the S&P 500's rise of 17.4% [3] Financial Performance - In Q3 2025, CDE's revenue rose by 77% to $555 million, driven by balanced output across five North American mines [6][11] - The company generated $237.7 million in operating cash flow during Q3, more than doubling its cash on hand to $266.3 million and reducing net leverage to 0.1X [12][13] - CDE repaid over $228 million of debt in the first nine months of 2025, bringing total debt down to $363.5 million [13] Operational Highlights - CDE's diversified North American portfolio includes five mines, with revenue contributions of approximately 23% from Palmarejo, 22% from Kensington, 20% from Rochester, 18% from Wharf, and 17% from Las Chispas [10][11] - The company is executing a significant exploration program with a commitment of $67-$77 million aimed at extending mine lives and improving grades [17] Growth Drivers - The Rochester silver-gold mine is a key growth engine, with recent expansions increasing throughput capacity [15] - The acquisition of Las Chispas has added a high-grade, low-cost asset to CDE's portfolio, enhancing production and cash flow [16] Earnings Estimates - The Zacks Consensus Estimate for CDE's fiscal 2025 earnings is currently at 91 cents per share, indicating a year-over-year growth of 406% [20] - For 2026, the estimate is pegged at $1.89 per share, reflecting a year-over-year increase of 107.14% [20] Investment Outlook - CDE's strong revenue growth, solid cash generation, and improved balance sheet position it as a favorable investment opportunity for those seeking exposure to precious metals [21]

Core Viewpoint - Ascentage Pharma has received investigational new drug (IND) application clearance for its novel BTK-targeted protein degrader, APG-3288, from the China Center for Drug Evaluation (CDE), following similar clearance from the U.S. FDA, marking a significant milestone in its clinical development for patients with relapsed/refractory hematologic malignancies [1][6]. Group 1: Drug Development and Clinical Trials - APG-3288 is set to enter a multicenter, open-label Phase I study to evaluate its safety, tolerability, pharmacokinetic profile, and preliminary efficacy in patients with relapsed/refractory hematologic malignancies [2]. - The IND clearance for APG-3288 enhances Ascentage Pharma's pipeline in hematologic malignancies, complementing existing products like Olverembatinib and Lisaftoclax, which have already been approved in China [5]. Group 2: Mechanism of Action and Innovation - APG-3288 utilizes Ascentage Pharma's proprietary PROTAC technology to induce the degradation of BTK, overcoming resistance associated with conventional BTK inhibitors by blocking the BCR-BTK signaling axis at its source [4]. - The drug is designed to provide a novel therapeutic strategy by inducing rapid and sustained degradation of both wild-type BTK and multiple BTK mutants, addressing the urgent clinical need for new treatment options in B-cell malignancies [3][4]. Group 3: Company Background and Strategy - Ascentage Pharma is a global biopharmaceutical company focused on developing innovative therapies for cancer, with a strong presence in hematologic malignancies and a diverse pipeline of drug candidates [8]. - The company has established partnerships with leading biotechnology and pharmaceutical firms, enhancing its research and development capabilities and expanding its global reach [11].

Core Insights - Coeur Mining's stock has experienced a significant decline, falling 6.1% recently and 24% since reaching an all-time high of nearly $26 per share on January 27 [1] - The drop in Coeur Mining's stock price is attributed to falling gold and silver prices, with gold prices dropping from an all-time high of $5,419.80 per ounce to below $4,660, and silver prices falling from $116.58 to $76.67 [3][4] Company Performance - Coeur Mining's current stock price is $19.47, with a market capitalization of $13 billion [5] - The stock has a gross margin of 31.80% and a trailing P/E ratio of 30, but a forward P/E ratio of less than 10 due to expected earnings growth of 90% next year, resulting in a PEG ratio of about 0.3 [6][7] Market Context - The decline in precious metal prices is seen as a potential buying opportunity for Coeur Mining stock, as analysts suggest that despite the current price drop, the long-term outlook remains positive [8]

Core Viewpoint - Precious metal prices have rebounded after three consecutive days of decline, leading to a widespread rally in gold and silver mining stocks [1][2]. Gold Mining Companies - Newmont increased by 4.0% - Barrick Mining rose by 4.3% - Agnico Eagle Mines saw a rise of 3.8% - Franco-Nevada grew by 2.1% - Kinross Gold climbed by 4.4% - New Gold surged by 5.2% [1][2]. Silver Mining Companies - Coeur Mining experienced a 6.0% increase - Endeavour Silver rose by 5.7% - Pan American Silver also increased by 5.7% - Silvercorp Metals saw a rise of 5.0% [1][2]. Spot Prices - Spot gold prices rose by 6.2% at one point - Spot silver prices increased by 12% at one point [3].

Core Viewpoint - MetalQuest Mining Inc. has entered into an option agreement to potentially acquire a 100% interest in the West Cameron Gold Project, marking its entry into gold exploration and diversifying its portfolio [1][3][4]. Agreement Details - The agreement provides a 40-day due diligence period, followed by an additional five business days for the company to issue a notice to proceed [2]. - If the company proceeds, it will pay a total of CAD $75,000 in cash and shares over three years, subject to a 2% Net Smelter Royalty [20]. Project Overview - The West Cameron Gold Project spans approximately 1,700 hectares and is located in the Kenora Mining District, Ontario, benefiting from established infrastructure and year-round access [7][9]. - The project is adjacent to First Mining Gold Corp.'s Cameron Gold Project, which has significant mineral resources [10]. Exploration Potential - Historical surface sampling has returned gold values up to 9.18 g/t Au, indicating promising mineralization [11]. - The project features gold mineralization associated with shear zones and an interpreted regional fault trend, which is considered favorable for exploration [14][15]. Strategic Importance - The Kenora Mining District is emerging as an active exploration region, supported by improved commodity prices and renewed interest from the industry [6]. - The acquisition aligns with the company's strategy to build a portfolio of strong exploration assets in premier mining jurisdictions [4]. Community Engagement - The company plans to engage with local First Nation communities to pursue collaborative partnerships, emphasizing its commitment to responsible exploration [7]. Industry Context - Recent acquisitions in the region, including significant transactions by Coeur Mining and First Mining Gold Corp., highlight growing interest and activity in the Kenora Mining District [12].